Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that “Super Intelligence” (SI) is being used in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:33:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T21:00:37.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now shows revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T22:05:47.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The study page for NCT04908189 now returns a 403 Forbidden page, replacing the previously visible trial details. The core content and study metadata that defined the record have been removed from the page in favor of the error screen.
    Difference
    19%
    Check dated 2026-09-20T20:42:15.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added IPD sharing information for the study, including Plan Description, access criteria, time frame, and the IPD Sharing URL. The update also includes policy language from Bristol-Myers Squibb about providing access to anonymized participant data to qualified researchers.
    Difference
    0.5%
    Check dated 2026-09-13T21:51:08.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a software version update. This change updates the page’s revision metadata rather than altering study content or data.
    Difference
    0.0%
    Check dated 2026-08-30T22:36:19.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.